Resumen
This retrospective cohort study of cancer decedents during 2004–2015 examined end-of-life cancer care quality indicators (QIs) in the provinces of British Columbia (BC), Ontario, and Nova Scotia (NS). These included: emergency department use, in-patient hospitalization, intensive care unit admissions, physician house calls, home care visits, and death experienced in hospital. Ontario saw the greatest 12-year decrease in in-hospital deaths from 52.8% to 41.1%. Hospitalization rates within 30 days of death decreased in Ontario, increased in NS, and remained the same in BC. Ontario’s usage of aggressive end-of-life measures changed very little, while BC increased their utilization rates. Supportive care use increased in both NS and Ontario. Those who were male or living in a lower income/smaller community (in Ontario) were associated with a decreased likelihood of receiving supportive care. Despite the shift in focus to providing hospice and home care services, approximately 50% of oncology patients are still dying in hospital and 11.7% of patients overall are subject to aggressive care measures that may be out of line with their desire for comfort care. Supportive care use is increasing, but providers must ensure that Canadians are connected to palliative services, as its utilization improves a wide variety of outcomes.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 4673-4685 |
Número de páginas | 13 |
Publicación | Current Oncology |
Volumen | 28 |
N.º | 6 |
DOI | |
Estado | Published - dic. 2021 |
Nota bibliográfica
Funding Information:Funding: This study was funded by the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC receives core funding from the Canadian Cancer Society Research Institute (Grant No. 2020-706936). In Ontario, the study used databases maintained by the Institute for Clinical Evaluative Sciences, which receives funding from the Ontario Ministry of Health and Long-Term Care.
Funding Information:
This study was funded by the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC receives core funding from the Canadian Cancer Society Research Institute (Grant No. 2020-706936). In Ontario, the study used databases maintained by the Institute for Clinical Evaluative Sciences, which receives funding from the Ontario Ministry of Health and Long-Term Care. The authors thank Anastasia Gayowsky and Urun Erbas-Oz for analysis support and Erin O’Leary for project management. Parts of this material are based on data and information compiled by CIHI, Cancer Care Ontario (CCO), and Ontario Registrar General (ORG) information on deaths, the original source of which is ServiceOntario. The BC Cancer Agency and the British Columbia Ministry of Health approved access to and use of the data held by Population Data BC for this study. Portions of the data used in this report were made available by the Nova Scotia Department of Health and Wellness and the Population Health Research Unit (now known as Health Data Nova Scotia) of Dalhousie University. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding and data provision sources.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
ASJC Scopus Subject Areas
- Oncology
PubMed: MeSH publication types
- Journal Article